ORPHAN DRUGS VERSUS ULTRA-ORPHAN DRUGS: PRICE COMPARISON IN ENGLAND

被引：0
|
作者：
Chachoua, L. [1 ]
Hanna, E. [2 ]
Zhou, J. [3 ]
Dussart, C. [4 ]
Toumi, M. [3 ]
机构：
[1] Market Access Soc, Paris, France
[2] Creat Ceut, Paris, France
[3] Aix Marseille Univ, Marseille, France
[4] Lyon 1 Univ, Lyon, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.822
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY6
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [41] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
    Makoto Shiragami
    Kiyohito Nakai
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
  • [42] Orphan drugs Relating price determination to disease prevalence
    Messori, Andrea
    Cicchetti, Americo
    Patregani, Luigi
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 341
  • [43] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
    Shiragami, M
    Nakai, K
    DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
  • [44] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
    Ounsirithupsakul, T.
    Samphansompoch, T.
    Sermsakulthai, T.
    Taychakhoonavudh, S.
    VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [45] ORPHAN DRUGS: WHAT FACTORS IMPACT THE PRICE IN FRANCE?
    De Joannis, P. E.
    Borget, I
    VALUE IN HEALTH, 2019, 22 : S784 - S785
  • [46] REIMBURSED PRICE OF ORPHAN DRUGS: A VALUE BASED FRAMEWORK
    Mincarone, P.
    Leo, C. G.
    Sabina, S.
    Tordrup, D.
    Taruscio, D.
    Kanavos, P.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [47] PRICE LIFE CYCLE MANAGEMENT OF ORPHAN DRUGS IN FRANCE
    Lebreton, C.
    Avot, D.
    Morand, F.
    Laigle, V
    Troubat, A.
    VALUE IN HEALTH, 2017, 20 (09) : A660 - A660
  • [48] Analysing criteria for price and reimbursement of orphan drugs in Spain
    Badia, Xavier
    Gil, Alicia
    Luis Poveda-Andres, Jose
    Shepherd, John
    Tort, Marina
    FARMACIA HOSPITALARIA, 2019, 43 (04) : 121 - 127
  • [49] ORPHAN DISEASES AND ORPHAN DRUGS - SCHEINBERG, WALSHE
    QURESHI, B
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1987, 107 (04): : 160 - 160
  • [50] INITIATIVES THAT IMPACT PRICING AND REIMBURSEMENT OF ORPHAN (AND ULTRA ORPHAN) DRUGS: REVIEW OF EUROPEAN TRENDS
    Rousseau, B.
    Poinas, A.
    Oliver, L.
    Collings, H.
    VALUE IN HEALTH, 2017, 20 (09) : A695 - A696
12345